StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kyntra Bio's price to sales ratio was 3.2× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 0.3× to 18.0×, with a median of 4.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.2×−1.1
2025Dec 31, 20254.3×+3.3
2024Dec 31, 20241.0×+0.4
2023Dec 29, 20230.6×−11.7
2022Dec 30, 202212.2×+7.6
2021Dec 31, 20214.6×−23.7
2020Dec 31, 202028.3×+17.8
2019Dec 31, 201910.5×−18.5
2018Dec 31, 201828.9×+0.4
2017Dec 29, 201728.6×+20.7
2016Dec 30, 20167.8×−3.0
2015Dec 31, 201510.8×+7.3
2014Dec 31, 20143.5×–

More Kyntra Bio figures

See a number that looks wrong?